
Our goal was to attempt to establish zzso zzso control zzso zzso with medication directed to restoration of a zzso in the zzso zzso zzso in zzso patients with a diagnosis of a predominantly central type zzso Thirty zzso patients completed a medical zzso zzso patient protocol and brain magnetic resonance imaging and zzso zzso zzso zzso of zzso Treatment with zzso and zzso medication continued for 4-6 zzso A maintenance dose was continued when zzso control was zzso zzso and outcome questionnaires were zzso Of 30 patients, 21 completed the trial zzso zzso control lasting from 4-6 weeks to 3 years was reported by 19 of the 21 zzso The trial was not completed by 9 of the 30 zzso No patient experienced an increase in zzso intensity or zzso zzso brain zzso zzso zzso zzso in 10 patients revealed objective evidence of increased brain zzso Patients with a predominantly central type zzso experience significant zzso control with medication directed to the zzso zzso zzso 

